{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:54:05Z","timestamp":1792086845142,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000765","name":"UCL","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012617","name":"Moorfields Eye Hospital NHS Foundation Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012617","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UCL Institute of Ophthalmology"},{"name":"Moorfields Special Trustees"},{"name":"Helen Hamlyn Trust"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002089","name":"Fight for Sight","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002089","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Freemasons Grand Charity"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.actbio.2017.10.015","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T20:00:40Z","timestamp":1507838440000},"page":"126-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Electrospun formulations of bevacizumab for sustained release in the eye"],"prefix":"10.1016","volume":"64","author":[{"given":"Ukrit","family":"Angkawinitwong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Awwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng T.","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Brocchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2017.10.015_b0005","first-page":"CD005139","article-title":"Anti-vascular endothelial growth factor for neovascular age-related macular degeneration","volume":"8","author":"Solomon","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.actbio.2017.10.015_b0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00006982-200410000-00002","article-title":"Risks of intravitreous injection: a comprehensive review","volume":"24","author":"Jager","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.actbio.2017.10.015_b0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2014.06.043","article-title":"Ocular delivery of macromolecules","volume":"190","author":"Kim","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2017.10.015_b0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: an overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J. Pharmacol."},{"key":"10.1016\/j.actbio.2017.10.015_b0025","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1167\/iovs.08-2662","article-title":"Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery","volume":"50","author":"Li","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1016\/j.actbio.2017.10.015_b0030","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1089\/ten.tea.2012.0455","article-title":"Scaffold-based delivery of a clinically relevant anti-angiogenic drug promotes the formation of in vivo stable cartilage","volume":"19","author":"Centola","year":"2013","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.actbio.2017.10.015_b0035","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3109\/02652048.2014.913727","article-title":"Double-effective chitosan scaffold-PLGA nanoparticle system for brain tumour therapy: in vitro study","volume":"31","author":"Kutlu","year":"2014","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.actbio.2017.10.015_b0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/bm2009558","article-title":"Extended release of bevacizumab by thermosensitive biodegradable and biocompatible hydrogel","volume":"13","author":"Wang","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2017.10.015_b0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.4.2.5","article-title":"Chau, Injectable chemically crosslinked hydrogel for the controlled release of bevacizumab in vitreous: A 6-month in vivo study","volume":"4","author":"Yu","year":"2015","journal-title":"Trans. Vis. Sci. Technol."},{"key":"10.1016\/j.actbio.2017.10.015_b0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/1874364101206010054","article-title":"Controlled release of bevacizumab through nanospheres for extended treatment of age-related macular degeneration","volume":"6","author":"Li","year":"2012","journal-title":"Open Ophthalmol. J."},{"key":"10.1016\/j.actbio.2017.10.015_b0055","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1038\/s41598-017-03959-4","article-title":"B, Sarmento, A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles","volume":"7","author":"Sousa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2017.10.015_b0060","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4155\/tde.12.17","article-title":"Electrospun nanofibers in drug delivery: recent developments and perspectives","volume":"3","author":"Williams","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.actbio.2017.10.015_b0065","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1002\/anie.200604646","article-title":"Electrospinning: a fascinating method for the preparation of ultrathin fibers","volume":"46","author":"Greiner","year":"2007","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.actbio.2017.10.015_b0070","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1039\/C4CS00226A","article-title":"Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals","volume":"44","author":"Sridhar","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actbio.2017.10.015_b0075","doi-asserted-by":"crossref","unstructured":"A.L. Yarin, B. Pourdeyhimi, S. Ramakrishna, Electrospinning of micro-and nanofibers, in: Fundam. Appl. Micro-and Nanofibers, 1st ed., Cambridge University Press, Cambridge, 2014: pp. 179\u2013261.","DOI":"10.1017\/CBO9781107446830.006"},{"key":"10.1016\/j.actbio.2017.10.015_b0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejpb.2004.10.006","article-title":"Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles","volume":"59","author":"Bilati","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2017.10.015_b0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0168-3659(03)00097-X","article-title":"Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA\u2013PEG block copolymers","volume":"89","author":"Luu","year":"2003","journal-title":"J. Control. Release."},{"key":"10.1016\/j.actbio.2017.10.015_b0090","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/marc.200800163","article-title":"Field-driven surface segregation of biofunctional species on electrospun PMMA\/PEO microfibers","volume":"29","author":"Sun","year":"2008","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.actbio.2017.10.015_b0095","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1016\/j.actbio.2010.05.025","article-title":"Fibrous scaffolds loaded with protein prepared by blend or coaxial electrospinning","volume":"6","author":"Ji","year":"2010","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2017.10.015_b0100","first-page":"391","article-title":"The flow of aqueous humor in the human eye","volume":"80","author":"Brubaker","year":"1982","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.actbio.2017.10.015_b0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0002-9394(98)00436-X","article-title":"Aqueous humor dynamics in the aging human eye","volume":"127","author":"Toris","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.actbio.2017.10.015_b0110","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.actbio.2017.10.015_b0115","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s11426-010-3180-3","article-title":"Electrospinning of ultrafine core\/shell fibers for biomedical applications","volume":"53","author":"Zhang","year":"2010","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.actbio.2017.10.015_b0120","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1021\/bm2017146","article-title":"Effect of pH on protein distribution in electrospun PVA\/BSA composite nanofibers","volume":"13","author":"Tang","year":"2012","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.actbio.2017.10.015_b0125","unstructured":"Genentech, Avastin(R) (bevacizumab) [package insert], Genentech, Inc. (2004). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/125085s0169lbl.pdf (accessed May 3, 2017)."},{"key":"10.1016\/j.actbio.2017.10.015_b0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/HAB-2011-0244","article-title":"Effects of dilution and prolonged storage with preservative in a polyethylene container on Bevacizumab (Avastin\u2122) for topical delivery as a nasal spray in anti-hereditary hemorrhagic telangiectasia and related therapies","volume":"20","author":"Kaja","year":"2011","journal-title":"Hum. Antibodies."},{"key":"10.1016\/j.actbio.2017.10.015_b0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.chroma.2007.12.046","article-title":"Pharmaceutical applications of isoelectric focusing on microchip with imaged UV detection","volume":"1181","author":"Vl\u010dkov\u00e1","year":"2008","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.actbio.2017.10.015_b0140","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.progpolymsci.2010.04.002","article-title":"The return of a forgotten polymer\u2014Polycaprolactone in the 21st century","volume":"35","author":"Woodruff","year":"2010","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.actbio.2017.10.015_b0145","series-title":"Disulfide-bridging PEGylation of antibody fragments","author":"Khalili","year":"2012"},{"key":"10.1016\/j.actbio.2017.10.015_b0150","unstructured":"TA Instruments, Discovery TGA User Manual."},{"key":"10.1016\/j.actbio.2017.10.015_b0155","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1002\/jps.24480","article-title":"The PK-Eye: A novel in vitro ocular flow model for use in preclinical drug development","volume":"104","author":"Awwad","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2017.10.015_b0160","series-title":"Pharmacokinetics of intravitreally applied VEGF inhibitors","author":"Krohne","year":"2016"},{"key":"10.1016\/j.actbio.2017.10.015_b0165","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00417-013-2495-0","article-title":"Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes","volume":"252","author":"Moisseiev","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.actbio.2017.10.015_b0170","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/IAE.0b013e318217373c","article-title":"Intraocular pharmacokinetics after a single intravitreal injection of 1.5mg versus 3.0mg of bevacizumab in humans","volume":"31","author":"Meyer","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.actbio.2017.10.015_b0175","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.ophtha.2008.04.023","article-title":"Vitreous levels of Bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization","volume":"115","author":"Zhu","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2017.10.015_b0180","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.iae.0000233327.68433.02","article-title":"Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients","volume":"26","author":"Beer","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.actbio.2017.10.015_b0185","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2017.10.015_b0190","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1007\/s10853-014-8352-7","article-title":"Tetracycline hydrochloride (TCH)-loaded drug carrier based on PLA:PCL nanofibre mats: experimental characterisation and release kinetics modelling","volume":"49","author":"Haroosh","year":"2014","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.actbio.2017.10.015_b0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2005.08.006","article-title":"A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents","volume":"108","author":"Jiang","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2017.10.015_b0200","doi-asserted-by":"crossref","unstructured":"R. Siegel, M. Rathbone, Overview of controlled release mechanisms, in: Fundam. Appl. Control. Release Drug Deliv., 1st ed., Springer US, New York, 2012: pp. 19\u201343.","DOI":"10.1007\/978-1-4614-0881-9_2"},{"key":"10.1016\/j.actbio.2017.10.015_b0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0168-3659(87)90034-4","article-title":"A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs","volume":"5","author":"Ritger","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2017.10.015_b0210","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/17425241003602259","article-title":"Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems","volume":"7","author":"Fu","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.actbio.2017.10.015_b0215","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1021\/la702449k","article-title":"Desorption-limited mechanism of release from polymer nanofibers","volume":"24","author":"Srikar","year":"2008","journal-title":"Langmuir"},{"key":"10.1016\/j.actbio.2017.10.015_b0220","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/mp800160p","article-title":"Mechanistic examination of protein release from polymer nanofibers","volume":"6","author":"Gandhi","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2017.10.015_b0225","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4161\/mabs.3.3.15608","article-title":"Fragmentation of monoclonal antibodies","volume":"3","author":"Vlasak","year":"2011","journal-title":"MAbs"},{"key":"10.1016\/j.actbio.2017.10.015_b0230","doi-asserted-by":"crossref","first-page":"7930","DOI":"10.1021\/ma5016616","article-title":"Core-liquid-induced transition from coaxial electrospray to electrospinning of low-viscosity poly(lactide-co-glycolide) sheath solution","volume":"47","author":"Luo","year":"2014","journal-title":"Macromolecules"},{"key":"10.1016\/j.actbio.2017.10.015_b0235","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2008.09.004","article-title":"Mathematical modeling of drug delivery","volume":"364","author":"Siepmann","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2017.10.015_b0240","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1110\/ps.8.3.625","article-title":"Trifluoroethanol-induced conformational transitions of proteins: insights gained from the differences between alpha-lactalbumin and ribonuclease A","volume":"8","author":"Gast","year":"1999","journal-title":"Protein Sci."},{"key":"10.1016\/j.actbio.2017.10.015_b0245","unstructured":"P. Khaw, S. Brocchini, H. Khalili, Composition for intraocular implantation of bevacizumab. US patent 9186414, 2010."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706117306323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706117306323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:01:17Z","timestamp":1761670877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706117306323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":49,"alternative-id":["S1742706117306323"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2017.10.015","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrospun formulations of bevacizumab for sustained release in the eye","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2017.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}